Serum Eicosapentaenoic and Arachidonic Acids Concentration and Cognitive Function in Patients With Coronary Artery Disease.

Abstract

INTRODUCTION

Recent studies have shown that Polyunsaturated Fatty Acids (PUFAs), including eicosapentaenoic acid (EPA), and Arachidonic Acid (AA), are associated with cognitive functions in patients with Coronary Artery Disease (CAD). Nevertheless, controversial results have been reported, too. The current study aimed to clarify the association of serum epa and AA levels with cognitive decline in an Iranian sample with CAD.

METHODS

We evaluated cognitive function with the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), in relation to serum levels of epa and AA, in 179 CAD patients. The associations between the MMSE and MoCA scores and the other demographic parameters were evaluated.

RESULTS

Patients with CAD generally had mild cognitive impairment. But we could not find any significant correlation between PUFAs and cognitive function. However, BMI was associated with EPA/MoCA; age was associated with MMSE/MoCA and BMI. Finally, the correlation between sex and MMSE/MoCA was significant.

CONCLUSION

Subjects generally had mild cognitive impairment, but we could not find any significant correlation between serum epa and AA levels with cognitive function.